New Hope Beyond Minoxidil and Finasteride
For decades, minoxidil and finasteride have been the go-to approved medications for hair thinning and androgenetic alopecia (pattern hair loss). Minoxidil—usually applied topically—can modestly increase hair count by promoting blood flow to dormant follicles, while finasteride reduces the hormone DHT that contributes to follicle miniaturization. However, these treatments often require long-term use, and finasteride comes with potential hormonal side effects that make it unsuitable for some people, particularly many women of childbearing age. As a result, both patients and researchers have sought alternatives that are safer, more effective, and capable of stimulating true regrowth rather than merely slowing loss.
Emerging Drugs and Novel Topicals
In the last few years, several next-generation pharmacological options have entered clinical trials. One standout is clascoterone, a topical androgen receptor blocker showing promising results in large phase III trials for male pattern hair loss. Unlike older hormonal drugs, clascoterone targets androgen activity directly in the scalp with minimal systemic absorption, offering hope for regrowth with fewer side effects. Other investigational molecules, such as GT-20029 (a PROTAC-based androgen receptor degrader) and PP405 (a small molecule designed to awaken dormant follicle stem cells), are advancing through clinical stages and could represent future hair regrowth paradigms if approved. Meanwhile, new systemic biologics like ABS-201, an AI-designed antibody against the prolactin receptor, aim to reactivate follicles at a molecular level.
Regenerative and Combination Approaches
Beyond drugs, regenerative medicine is reshaping how clinicians think about hair restoration. Treatments like platelet-rich plasma (PRP) and photobiomodulation (low-level laser therapy) already have clinical use for androgenetic alopecia and alopecia areata, leveraging growth factors and light-induced cellular signaling to spur follicle activity. More recently, research into stem cells and exosomes—small extracellular vesicles that can carry growth-promoting signals—has shown potential in early studies to enhance follicle repair and reduce inflammation. While these modalities are still experimental and require more rigorous clinical evidence, they represent an exciting, biology-based frontier for those who haven’t responded to conventional therapies.
A New Frontier: Wearable Light Therapy for Hair Growth
In recent years, wearable light-therapy devices like caps and helmets have emerged as an intriguing non-invasive option for people experiencing thinning or balding. These devices use low-level laser therapy (LLLT) — a form of red or near-infrared light that penetrates the scalp to stimulate cellular energy in hair follicles, potentially encouraging growth and reducing shedding. Clinical research and dermatologists alike note that consistent use over several months (often 4–6 months or more) may lead to measurable improvements in hair density and follicle health, especially when started in the early stages of hair loss rather than later, advanced balding. While outcomes vary and results aren’t instant, LLLT hats are appealing because they can be used hands-free at home and are generally well-tolerated without the side effects associated with some medications.
For those curious about trying light therapy, here are some popular options that use this technology:
What This Means for People Balding Today
The landscape for hair loss treatments is more active than it’s been in decades. Established therapies still play a crucial role, but these next-wave options—from novel targeted drugs and biologics to regenerative therapies—promise more personalized and potentially more effective strategies for both men and women. As always, outcomes vary with the cause of hair loss (e.g., hormonal vs. autoimmune) and the individual’s biology. Consulting a dermatologist or trichologist remains essential to tailor a treatment plan that reflects both current evidence and the latest scientific advances.
I hope this has given you some hope in your hair journey. Remember, as always, it is what is on the inside of us that counts the most.
In Gratitude,
KJ Landis
@superiorself on Instagram and X
@SuperiorSelf channel on YouTube
@superiorselfwithkjlandis on TikTok
[email protected]
Books available everywhere!
Bibliography
For decades, minoxidil and finasteride have been the go-to approved medications for hair thinning and androgenetic alopecia (pattern hair loss). Minoxidil—usually applied topically—can modestly increase hair count by promoting blood flow to dormant follicles, while finasteride reduces the hormone DHT that contributes to follicle miniaturization. However, these treatments often require long-term use, and finasteride comes with potential hormonal side effects that make it unsuitable for some people, particularly many women of childbearing age. As a result, both patients and researchers have sought alternatives that are safer, more effective, and capable of stimulating true regrowth rather than merely slowing loss.
Emerging Drugs and Novel Topicals
In the last few years, several next-generation pharmacological options have entered clinical trials. One standout is clascoterone, a topical androgen receptor blocker showing promising results in large phase III trials for male pattern hair loss. Unlike older hormonal drugs, clascoterone targets androgen activity directly in the scalp with minimal systemic absorption, offering hope for regrowth with fewer side effects. Other investigational molecules, such as GT-20029 (a PROTAC-based androgen receptor degrader) and PP405 (a small molecule designed to awaken dormant follicle stem cells), are advancing through clinical stages and could represent future hair regrowth paradigms if approved. Meanwhile, new systemic biologics like ABS-201, an AI-designed antibody against the prolactin receptor, aim to reactivate follicles at a molecular level.
Regenerative and Combination Approaches
Beyond drugs, regenerative medicine is reshaping how clinicians think about hair restoration. Treatments like platelet-rich plasma (PRP) and photobiomodulation (low-level laser therapy) already have clinical use for androgenetic alopecia and alopecia areata, leveraging growth factors and light-induced cellular signaling to spur follicle activity. More recently, research into stem cells and exosomes—small extracellular vesicles that can carry growth-promoting signals—has shown potential in early studies to enhance follicle repair and reduce inflammation. While these modalities are still experimental and require more rigorous clinical evidence, they represent an exciting, biology-based frontier for those who haven’t responded to conventional therapies.
A New Frontier: Wearable Light Therapy for Hair Growth
In recent years, wearable light-therapy devices like caps and helmets have emerged as an intriguing non-invasive option for people experiencing thinning or balding. These devices use low-level laser therapy (LLLT) — a form of red or near-infrared light that penetrates the scalp to stimulate cellular energy in hair follicles, potentially encouraging growth and reducing shedding. Clinical research and dermatologists alike note that consistent use over several months (often 4–6 months or more) may lead to measurable improvements in hair density and follicle health, especially when started in the early stages of hair loss rather than later, advanced balding. While outcomes vary and results aren’t instant, LLLT hats are appealing because they can be used hands-free at home and are generally well-tolerated without the side effects associated with some medications.
For those curious about trying light therapy, here are some popular options that use this technology:
- HigherDOSE Red Light Hat – A well-reviewed red-light cap that’s comfortable and portable for daily use.
- Hooga Red Light Therapy Hat – Highly rated wearable option with strong user feedback.
- LED Therapy Cap – Uses LLLT to stimulate follicles and can integrate into regular routines.
- iRestore Professional Laser Hair Growth System – A more advanced laser system with an adjustable fit and established clinical backing.
- Swirise Red Light Therapy Cap – A budget-friendly, highly rated choice with excellent reviews.
- Other wearable light options include 216‑led Red Light Therapy Hat, KTS Laser Hair Regrowth Cap, and Bon Charge Red Light Cap, offering a range of price points and LED/laser configurations.
What This Means for People Balding Today
The landscape for hair loss treatments is more active than it’s been in decades. Established therapies still play a crucial role, but these next-wave options—from novel targeted drugs and biologics to regenerative therapies—promise more personalized and potentially more effective strategies for both men and women. As always, outcomes vary with the cause of hair loss (e.g., hormonal vs. autoimmune) and the individual’s biology. Consulting a dermatologist or trichologist remains essential to tailor a treatment plan that reflects both current evidence and the latest scientific advances.
I hope this has given you some hope in your hair journey. Remember, as always, it is what is on the inside of us that counts the most.
In Gratitude,
KJ Landis
@superiorself on Instagram and X
@SuperiorSelf channel on YouTube
@superiorselfwithkjlandis on TikTok
[email protected]
Books available everywhere!
Bibliography
- Recent Advances in Drug Development for Hair Loss. Int. J. Mol. Sci. (2025).
- Hair Loss Treatment in 2026: The Evidence-Based Decision Framework. Charles Medical Group (2026).
RSS Feed